Literature DB >> 7521672

Erysipelas in neutropenia of unknown origin, successfully treated with r-metHuG-CSF (filgrastim)

M Müller-Lühr, N Breyer, A Martin, H Haacke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7521672     DOI： 10.1007/bf01698490

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  11 in total

1.  Successful treatment of methimazole-induced agranulocytosis by granulocyte colony-stimulating factor.

Authors:  K Yokoyama; T Sato; S Nakajima; M Chino; S Komatsumoto; M Nara; S Okamoto
Journal:  Am J Hematol       Date:  1992-05       Impact factor: 10.047

2.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

3.  Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.

Authors:  K Welte; C Zeidler; A Reiter; W Müller; E Odenwald; L Souza; H Riehm
Journal:  Blood       Date:  1990-03-01       Impact factor: 22.113

4.  Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.

Authors:  J Crawford; H Ozer; R Stoller; D Johnson; G Lyman; I Tabbara; M Kris; J Grous; V Picozzi; G Rausch
Journal:  N Engl J Med       Date:  1991-07-18       Impact factor: 91.245

5.  Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor.

Authors:  H Wandt; M Seifert; C Falge; W M Gallmeier
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

6.  Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF).

Authors:  A Willfort; C Lorber; S Kapiotis; S Sertl; R Hainz; P Kirchweger; U Jäger; P A Kyrle; K Lechner; K Geissler
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

7.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

8.  Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy.

Authors:  V Trillet-Lenoir; J Green; C Manegold; J Von Pawel; U Gatzemeier; B Lebeau; A Depierre; P Johnson; G Decoster; D Tomita
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

9.  Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium.

Authors:  J L Gabrilove; A Jakubowski; H Scher; C Sternberg; G Wong; J Grous; A Yagoda; K Fain; M A Moore; B Clarkson; Herbert F Oettgen; Kirby Alton; Karl Welte; Lawrence Souza
Journal:  N Engl J Med       Date:  1988-06-02       Impact factor: 91.245

10.  Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.

Authors:  M H Bronchud; J H Scarffe; N Thatcher; D Crowther; L M Souza; N K Alton; N G Testa; T M Dexter
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.